| Pharmaceutical care: the PCNE definition 2013 SS Allemann, JWF van Mil, L Botermann, K Berger, N Griese, ... International journal of clinical pharmacy 36, 544-555, 2014 | 340 | 2014 |
| Matching adherence interventions to patient determinants using the theoretical domains framework SS Allemann, R Nieuwlaat, BJF Van den Bemt, KE Hersberger, I Arnet Frontiers in pharmacology 7, 429, 2016 | 71 | 2016 |
| Congruence between patient characteristics and interventions may partly explain medication adherence intervention effectiveness: an analysis of 190 randomized controlled trials … SS Allemann, R Nieuwlaat, T Navarro, B Haynes, KE Hersberger, I Arnet Journal of clinical epidemiology 91, 70-79, 2017 | 51 | 2017 |
| TEOS: A framework for constructing operational definitions of medication adherence based on Timelines–Events–Objectives–Sources AL Dima, SS Allemann, J Dunbar‐Jacob, DA Hughes, B Vrijens, IB Wilson British journal of clinical pharmacology 87 (6), 2521-2533, 2021 | 36 | 2021 |
| Adherence to long-term therapies in cystic fibrosis: a French cross-sectional study linking prescribing, dispensing, and hospitalization data H Rouzé, M Viprey, S Allemann, AL Dima, P Caillet, A Denis, ... Patient preference and adherence, 1497-1510, 2019 | 22 | 2019 |
| Issues around the prescription of half tablets in Northern Switzerland: the irrational case of quetiapine SS Allemann, D Bornand, B Hug, KE Hersberger, I Arnet BioMed research international 2015 (1), 602021, 2015 | 21 | 2015 |
| Beyond adherence thresholds: a simulation study of the optimal classification of longitudinal adherence trajectories from medication refill histories SS Allemann, D Dediu, AL Dima Frontiers in pharmacology 10, 383, 2019 | 19 | 2019 |
| Methodological considerations on estimating medication adherence from self‐report, electronic monitoring and electronic healthcare databases using the TEOS framework AL Dima, SS Allemann, J Dunbar‐Jacob, DA Hughes, B Vrijens, IB Wilson British Journal of Clinical Pharmacology 89 (7), 1918-1927, 2023 | 16 | 2023 |
| Patient views on an electronic dispensing device for prepackaged polypharmacy: a qualitative assessment in an ambulatory setting SS Allemann, KE Hersberger, I Arnet Integrated Pharmacy Research and Practice, 167-174, 2015 | 13 | 2015 |
| A guide to a pharmacist-led pharmacogenetic testing and counselling service in an interprofessional healthcare setting CK Stäuble, C Jeiziner, A Bollinger, FM Wiss, M Hatzinger, KE Hersberger, ... Pharmacy 10 (4), 86, 2022 | 12 | 2022 |
| Adherence patterns in antiseizure medications influencing risk of sudden unexplained death in epilepsy: a data linkage study using dispensed prescriptions M Tan, SS Allemann, XS Qin, WJ D'Souza Epilepsia 64 (3), 641-653, 2023 | 10 | 2023 |
| Pharmacist-guided pre-emptive pharmacogenetic testing in antidepressant therapy (PrePGx): Study protocol for an open-label, randomized controlled trial CK Stäuble, ML Lampert, S Allemann, M Hatzinger, KE Hersberger, ... Trials 22, 1-11, 2021 | 10 | 2021 |
| National poison center calls before vs after availability of high-dose acetaminophen (paracetamol) tablets in Switzerland A Martinez-De la Torre, S Weiler, DS Bräm, SS Allemann, ... JAMA network open 3 (10), e2022897-e2022897, 2020 | 8 | 2020 |
| AdhereR: an open science approach to estimating adherence to medications using electronic healthcare databases A Dima, S Allemann, D Dediu MEDINFO 2019: Health and Wellbeing e-Networks for All, 1451-1452, 2019 | 8 | 2019 |
| Swiss priority setting on implementing medication adherence interventions as part of the European ENABLE COST action C Bandiera, J Ribaut, AL Dima, SS Allemann, K Molesworth, K Kalumiya, ... International journal of public health 67, 1605204, 2022 | 7 | 2022 |
| Pharmacogenetic analysis enables optimization of pain therapy: a case report of ineffective oxycodone therapy FM Wiss, CK Stäuble, HE Meyer zu Schwabedissen, SS Allemann, ... Journal of Personalized Medicine 13 (5), 829, 2023 | 5 | 2023 |
| Development and acceptance of a new adherence monitoring package to identify non-adherent patients with polypharmacy in primary care: a feasibility study F Dietrich, A Zeller, S Allemann, I Arnet BMJ Open Quality 12 (1), e002155, 2023 | 5 | 2023 |
| Utilization of drugs with pharmacogenetic dosing recommendations in Switzerland: a descriptive study using the helsana database NL Wittwer, CR Meier, CA Huber, HE Meyer zu Schwabedissen, ... Pharmacogenomics and Personalized Medicine, 967-976, 2022 | 5 | 2022 |
| Case report: Non-response to fluoxetine in a homozygous 5-HTTLPR S-allele carrier of the serotonin transporter gene CK Stäuble, R Meier, ML Lampert, T Mikoteit, M Hatzinger, SS Allemann, ... Frontiers in Psychiatry 13, 942268, 2022 | 3 | 2022 |
| Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis?–A Case Report C Jeiziner, SS Allemann, KE Hersberger, HE Meyer zu Schwabedissen Pharmacogenomics and Personalized Medicine, 465-475, 2022 | 3 | 2022 |
Alexandra L. DimaAvedis Donabedian Research Institute; Sant Joan de Déu Research InstituteVerified email at fadq.org
